Skip to main content
. 2012 Oct 25;12:495. doi: 10.1186/1471-2407-12-495

Table 5.

EORTC QLQ-BR23 mean scores (SE) at each time point

  CR & TT at T0
CR at T1
TT at T1
CR at T2
TT at T2
CR at T3
TT at T3
CR at T4
TT at T4
CR at T5
TT at T5
n=121 n=62 n=59 n=62 n=59 n=50 n=51 n=30 n=36 n=16 n=18
arm symptoms
24,33
21,00 (2,50)
18,07 (2,32)
21,24 (2,82)
18,01 (2,08)
22,02 (3,73)
26,33 (4,27)
19,89 (5,10)
19,96 (4,40)
11,14 (5,76)
18,78 (6,49)
breast symptoms
20,94
33,30 a (2,78)
29,57 (2,74)
23,67 (2,58)
24,10 (2,35)
17,99 (3,17)
15,94 (2,52)
14,55 (4,24)
12,60 (3,30)
6,87 (5,63)
16,77 (4,99)
body image
73,35
69,60 (2,14)
70,62 (2,49)
73,21 (2,48)
77,80 (2,55)
74,74 (3,67)
77,51 (2,87)
73,62 (5,76)
78,40 (4,93)
74,91 (7,02)
79,08 (7,36)
future perspective
53,44
57,33 (3,64)
51,02 (3,44)
58,36 (3,38)
58,62 (3,26)
61,78 (4,03)
65,44 (3,53)
64,55 (5,84)
64,55 (6,27)
59,69 (7,59)
68,03 (10,08)
systemic treatment side effects
14,64
22,50 (1,87)
25,81a (2,83)
22,52 (2,06)
21,21 (2,88)
18,01 (2,20)
17,88 (2,57)
19,40 (3,19)
13,20 (2,95)
17,62 (4,80)
15,24 (4,28)
 
n=21
n=22
n=26
n=16
n=20
n=8
n=10
n=8
n=6
n=3
n=3
upset by hair loss
34,92
48,25 a (8,16)
27,51 (9,26)
23,81 a (11,11)
40,48 a (5,56)
46,02 a (11,10)
28,25 a (16,33)
1,62 a (0,00)
23,81 (29,40)
34,92 a (0,00)
34,92 a (0,00)
 
n=104
n=53
n=50
n=53
n=53
n=42
n=45
n=26
n=30
n=13
n=15
sexual functioning
23,85
21,02 (2,68)
23,52 (3,45)
24,48 (3,04)
22,60 (3,36)
24,65 (3,50)
24,59 (2,90)
21,85 (4,44)
27,19 (3,61)
25,14 (6,92)
21,63 (5,36)
 
n=61
n=23
n=23
n=29
n=32
n=24
n=29
n=15
n=19
n=8
n=9
sexual enjoyment 55,74 53,98 (5,39) 47,40 (3,31) 48,16 (5,77) 50,61 (5,45) 61,29 a (4,86) 49,94 (4,98) 64,07 (5,98) 48,59 (5,16) 62,40 a (6,67) 46,21 (9,52)

a Indicates more or equal to ten-point difference from previous time point.

T0: baseline, T1: last day RT, T2: 3 months post-RT, T3: 1 year post-RT, T4: 2 years post-RT, T5: 3 years post-RT.